DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
19.90
+0.32 (1.63%)
Jan 22, 2026, 3:00 PM CST
44.52% (1Y)
| Market Cap | 22.66B |
| Revenue (ttm) | 26.83B |
| Net Income (ttm) | 1.14B |
| Shares Out | 1.14B |
| EPS (ttm) | 1.01 |
| PE Ratio | 19.67 |
| Forward PE | 18.09 |
| Dividend | 0.68 (3.47%) |
| Ex-Dividend Date | Nov 6, 2025 |
| Volume | 4,663,298 |
| Average Volume | 6,391,797 |
| Open | 19.59 |
| Previous Close | 19.58 |
| Day's Range | 19.45 - 20.04 |
| 52-Week Range | 13.50 - 19.99 |
| Beta | 0.65 |
| RSI | 70.86 |
| Earnings Date | Apr 24, 2026 |